The vitamin D endocrine system is a well-established target for metabolic bone disorders. Furthermore, the identification of the vitamin D receptor in tissues not related to calcium and bone has stimulated interest in its therapeutic significance in autoimmune diseases, cardiovascular disorders, infectious diseases and cancer. Plum and DeLuca highlight the emerging opportunities for vitamin D-based therapies in those diseases for which the evidence of their potential is most compelling.
- Lori A. Plum
- Hector F. DeLuca
